Feature | April 18, 2014

New Fusion Technology Increases Prostate Cancer Detection Accuracy to 97 Percent

Rush University Medical Center first in Chicago to use targeted biopsy approach

Prostate Biopsy Ultrasound MRI Rush Medical Center Chicago

April 18, 2014 — Urologists at Rush University Medical Center are the first in Chicago to offer a powerful new tool for visualizing and monitoring the prostate in men who have high prostate-specific antigen (PSA) levels and in detecting prostate cancer more accurately.

The new technology combines or “fuses” magnetic resonance (MR) and ultrasound images uses electromagnetic tracking/guidance, similar to your car’s GPS system. A tiny tracking sensor is attached to an ultrasound probe and generates a small, localized electromagnetic field that helps determine the location and orientation of the biopsy device. A sophisticated computer program maintains the fusion of MR and ultrasound images, even when a patient moves.

If necessary, physicians can make a precisely targeted biopsy or direct sampling of tissue in areas within the prostate that seem suspicious. Currently prostate biopsies are “blind,” meaning physicians must randomly sample the prostate, an approach that has been in use since the 1980s.

“By fusing these MRI images with real-time ultrasound, prostate biopsy can now be targeted directly toward specific areas of interest in the prostate,” said Ajay Nehra, chairman of urology at Rush University Medical Center.

The process involves a 20-minute procedure done in the clinic under local anesthesia, compared with less accurate and older method of prostate biopsy. Many men require multiple biopsies in order to make sure that all potentially cancerous areas are identified. This technology eliminates the need for multiple biopsies, at times up to 21.

“This is a new way of identifying and specifically targeting suspicious prostate lesions. We believe it may have the potential to be a new standard in prostate care,” said Nehra.

“The use of fusion technology increases the accuracy of prostate biopsy to 97 percent,” said Charles McKiel Jr., professor of urology at Rush University Medical Center. “This technology allows us to see tumors that may be missed by conventional prostate biopsy.”

Based on this diagnostic technology, doctors at Rush will soon begin a new clinical research trial called “focal therapy” for men with prostate cancer confined to one small area. Focal therapy treats only the area that is cancerous rather than the entire prostate gland, according to McKiel.

Other than skin cancer, prostate cancer has become the most common form of cancer in American men and the second-leading cause of cancer death in this population. According to the American Cancer Society, 1 of 6 men will be diagnosed with prostate cancer during his lifetime. It is the second leading cause of cancer death in men behind lung cancer.

For more information: www.newswise.com/institutions/newsroom/2670

Related Content

Sponsored Content | Videos | Magnetic Resonance Imaging (MRI) | December 07, 2017
Max Wintermark, M.D., professor of radiology and chief of neuroradiology, Stanford Hospital and Clinics, discussed MR
Hitachi Highlights Arietta 850 Premium Ultrasound System at RSNA 2017
News | Ultrasound Imaging | December 05, 2017
Hitachi Healthcare exhibited their latest premium ultrasound system, the Arietta 850, at the 2017 Radiological Society...
Brain's Appetite Regulator Disrupted in Obese Teens
News | Neuro Imaging | December 05, 2017
December 5, 2017 — Advanced...
Toshiba Launches Vantage Elan Zen Edition MR for Enhanced Patient Comfort
Technology | Magnetic Resonance Imaging (MRI) | December 05, 2017
Toshiba Medical, a Canon Group company, introduced its newest magnetic resonance (MR) system, the Vantage Elan/Zen...
Toshiba Medical Rolls Out Interactive Learning Tools for Ultrasound and Vascular Training
News | Ultrasound Imaging | December 04, 2017
Toshiba Medical, a Canon Group company, introduced new educational tools and interactive learning resources to help...
Siemens Healthineers Introduces GOKnee3D MR Application
News | Magnetic Resonance Imaging (MRI) | November 27, 2017
November 27, 2017 — At the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America
Samsung Unveils Mobile CT OmniTom at RSNA 2017
Technology | Computed Tomography (CT) | November 26, 2017
Samsung Electronics debuted its OmniTom mobile 16-slice computed tomography (CT) scanner at the Radiological Society of...
Carestream Receives Vizient Innovative Technology Designation for Touch Prime Ultrasound Systems
News | Ultrasound Imaging | November 22, 2017
Carestream Health announced its Carestream Touch Prime Ultrasound Systems have received a 2017 Innovative Technology...
Hitachi Healthcare Americas Introduces SynergyDrive MRI Workflow Solution
Technology | Magnetic Resonance Imaging (MRI) | November 21, 2017
November 21, 2017 — At the 2017 Radiological Society of North America (RSNA) annual meeting, Nov. 26-Dec.
Overlay Init